DEF 14AThe Ballot
Viking Therapeutics, Inc. files DEF 14A
Filed Apr 1, 2026 · 2mo ago · Accession 0001193125-26-137915
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Viking Therapeutics, Inc.
- Ticker
- VKTX
- CIK
- 1607678
- Form type
- DEF 14A
- Filing date
- Apr 1, 2026
- Report date
- May 19, 2026
- Document
- vktx-20260401.htm
- Size
- 3.9 MB